| http://www.w3.org/ns/prov#value | - The industry and its regulators, such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory bodies, are concerned that the drug supply chain is growing increasingly vulnerable to a variety of illegal activities that could have serious public health implications.
|
